Half-doses of the diabetes meds Avandia and metformin may help prevent pre-diabetes from turning into diabetes, Canadian researchers say. Fourteen percent of study participants given the low doses developed diabetes after four years, compared to 39 percent of people given placebo. The study, funded by Avandia's drugmaker, also found that the combination of drugs did not cause the common side effects such as weight gain, fluid retention, and GI upset. The study did not study patients long enough...
Read moreIn April 2009 I told you about a pilot study in which low-dose naltrexone (LDN) showed great promise as a fibromyalgia treatment. In that... Read more »
One of the cliches about treating diabetes is that having diabetes puts you in the same risk category as that of a person who has already... Read more »
You often hear nutrition experts extol the virtues of fruits and vegetables because of their nutrient content. Eating a variety of... Read more »
I've had some anxiety issues lately, so several days ago I decided to take one of my "as needed" medications, Klonopin (generic name... Read more »
Menopause brings about many changes to the body. Some of those we can see; other changes aren’t so visible. For instance, vaginal atrophy... Read more »
If you're younger than age 50 and have had a flu vaccine in the past, U.S. researchers say a half-dose flu shot may be enough to protect you from the... Read more »
(Ivanhoe Newswire) -- A half-dose flu shot may be just as effective in healthy, young people as a full dose, which could be useful during vaccine... Read more »
New research suggests that cardiologists should be giving patients higher doses of Plavix than is currently recommended before patients undergo... Read more »
A study published in Diabetes Care has found that 57 percent of diabetics have intentionally skipped a dose of insulin. One in five patients even... Read more »
Low-dose treatment with acetretin, a drug used to treat skin psoriasis, seems to help reduce nail psoriasis, according to Italian researchers. Read more »